Amneal-Impex combine to pip Sun Pharma as the fifth-largest generic maker in US News News / News 6 years ago 500 Views comments The combined company is expected to have 2017 pro forma net revenue ranging from USD 1.75 billion to USD 1.85 billion and pro forma adjusted EBITDA of... Read more
News Encroachment on privacy must withstand touchstone of permissible restrictions: SC News / News - 6 years ago
Comments